COMMUNIQUÉS West-GlobeNewswire

Progressive Care Reports 18% Increase in Year over Year Prescriptions Filled During February 2018
16/03/2018
MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces strong sales for the month of February 2018. PharmCo, LLC filled over 19,500 [...]
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
16/03/2018
Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can be safely monitored rather than undergo prostate biopsy MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( [...]
Atara Biotherapeutics to Present at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
16/03/2018
Post-transplant lymphoproliferative disorder (PTLD) following allogeneic hematopoietic cell transplant (HCT) is an aggressive disease impacting a young population and carrying a significant mortality rate in a [...]
Fortress Biotech Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
16/03/2018
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results
16/03/2018
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today financial results for the [...]
Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference
16/03/2018
SAN DIEGO, March 16, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Xbrane Biopharma: Comment to call for an extraordinary general meeting
16/03/2018
Press release 2018-03-16 Xbrane Biopharma hereby calls for an extraordinary general meeting on Tuesday, April 3, 2018 at. 17.30 in Spårvagnshallarna, Birger Jarlsgatan 57 A, Stockholm. The reason for the call for [...]
Xbrane Biopharma AB: Notice of extra general meeting in Xbrane Biopharma AB
16/03/2018
Press release 2018-03-16 The shareholders of Xbrane Biopharma AB, reg. no. 556749-2375, (the "Company"), are hereby convened to an extra general meeting to be held on Tuesday 3 April 2018, at 17.30 p.m. at [...]
TearLab Corporation Announces Voluntary Delisting From Toronto Stock Exchange
16/03/2018
SAN DIEGO, March 16, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”) today announced that it has applied and received approval for a voluntary delisting of its common [...]
Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin™ Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial
16/03/2018
SHANGHAI, China and CUPERTINO, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
Nabriva Therapeutics Reports 2017 Financial Results and Recent Corporate Highlights
16/03/2018
- Positive topline results from pivotal LEAP 1 trial announced in September 2017, with read-out from second Phase 3 trial, LEAP 2, expected in the spring of 2018 - - $86.9 million cash and investments as of December 31 [...]
Cannabis Wheaton Income Corp. Provides Update on the Initial Development of FV Pharma Inc. Facility
16/03/2018
VANCOUVER, British Columbia, March 16, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to provide an update on the initial development of its [...]
Ascendis Pharma A/S Announces Year-End 2017 Financial Results and Business Update Conference Call on March 28
16/03/2018
COPENHAGEN, Denmark, March 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in [...]
Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease
16/03/2018
Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones Foliglurax is a first-in-class treatment which entered [...]
Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 Results
16/03/2018
KENNETT SQUARE, Pa., March 16, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced operating results for [...]
Articles of Association
16/03/2018
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) Articles of Association most recently amended by the shareholders at the AGM held on 12 March 2018 ALKArticlesOfAssociation_12032018_final_approvedByAGM
Vistin Pharma ASA : Torbjørn Kjus joins Vistin to develop new business area
16/03/2018
Oslo, Norway, 16 March 2018 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) has entered into agreements with Torbjørn Kjus and Kenneth Tveter for the development of a new business area within energy trading activities. " [...]
Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test
16/03/2018
MELBOURNE, Australia, March 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]
DHAIS plc : Statement re Withdrawal from NEX Exchange
16/03/2018
16 March 2018 DHAIS PLC ("DHAIS" or "the Company") PROPOSED WITHDRAWAL FROM NEX EXCHANGE GROWTH MARKET DHAIS announces that the Company is today giving notice of its intention to withdraw its ordinary shares in the [...]

Pages